You are here
ADECTO PHARMACEUTICALS INC
UEI: DAR5SR7BVBB6
# of Employees: 3
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: Yes
Award Charts
Award Listing
-
Development of a Companion Diagnostic Assay for Detection of ADAM8-Positive Cancers
Amount: $300,000.00Triple negative breast cancersTNBCsaccount yearly forof all breast cancer deathsThe current Standard of CareSoCsurgeryradiation and chemotherapyCTis not curativeMore effectivetargeted treatments are u ...
SBIRPhase I2019Department of Health and Human Services National Institutes of Health -
Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
Amount: $2,002,084.00Triple negative breast cancersTNBCsaccount forof breast cancer deaths and lack targeted therapiesWe identified the non essentialcell surface protein ADAMas an important target on TNBCADAMis present in ...
SBIRPhase II2018Department of Health and Human Services National Institutes of Health -
Antibody targeting of ADAM for treatment of triple negative breast cancer
Amount: $413,490.00DESCRIPTION provided by applicant Triple negative breast cancers TNBCs account for of breast cancer deaths and lack targeted therapies Drs Sonenshein Mineva and Romagnoli and their co wor ...
STTRPhase I2016Department of Health and Human Services National Institutes of Health